New Abortion Pill Study Confirms Danger to Mothers

A new study from the Ethics and Public Policy Center (EPPC) confirms what many have been warning about for years. The abortion pill doesn’t just take the life of innocent preborn babies but also injures and puts mother’s lives in jeopardy.

“The Abortion Pill Harms Women,” the largest ever study of its kind, found that nearly 11% of all women who abort their child with mifepristone suffer from life-threatening conditions, including sepsis, infection or hemorrhaging.

Authored by Jamie Bryan Hall, EPPC’s Director of Data Analysis and EPPC president Ryan T. Anderson, the findings come just as the use of chemical (and often mail order) abortions are skyrocketing.

“This study is the statistical equivalent of a category 5 hurricane hitting the prevailing narrative of the abortion industry,” reflected Ryan T. Anderson.

“It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill. The Trump FDA should take immediate action to protect the safety of American women by reinstating the safety regulations that the Obama and Biden Administrations removed.”

The study, conducted between 2017 and 2023, found that women are 22 times more likely to be harmed than previously suggested by the Food and Drug Administration.

In the simplest of terms, this new study confirms that the public has been consistently lied to or deceived about the so-called safety of the abortion pill.

In releasing the study, the EPPC is wisely calling for the FDA to reinstate “patient safety protocols” that were first promised when mifepristone was first released. Additional requests include:

• Prescribing mifepristone and misoprostol for the termination of pregnancy should require at least three in-person office visits by the patient — as originally required by the FDA.
• Mifepristone should be prescribed only by physicians — as originally required by the FDA — who have read and understood the prescribing information.
• Mifepristone should be administered only in a clinic, medical office, or hospital, by or under the supervision of a physician, able to assess the gestational age of an embryo and to diagnose ectopic pregnancies — all of which was originally required by the FDA.
• Physicians must be able to provide surgical intervention in cases of incomplete abortion or severe bleeding, or have made plans to provide such care through others, and be able to assure patient access to medical facilities equipped to provide blood transfusions and resuscitation, if necessary.
• Healthcare providers should be required once again to report to the FDA (and manufacturers of mifepristone) all serious adverse events resulting from the use of mifepristone.
• Mifepristone should only be prescribed to a woman who is confirmed by a physician to be in the first seven weeks of pregnancy — as originally required by the FDA.

Abortion pill sycophants often dismiss warnings about the deadly pill as being hyperbole, but in releasing the new study, the EPPC even provides tragic testimonies from women who have suffered from its use.

Sadly, there are many no longer alive to talk.

Public policy impacts real people in real time and nowhere is this truer than when it comes to the reckless and tragic distribution of the abortion pill.

The FDA is long overdue to study and re-investigate the abortion pill’s so-called safety. This landmark new study will hopefully trigger and expedite that process.